nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7—Irinotecan—colon cancer	0.137	0.159	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.137	0.159	CbGbCtD
Dextropropoxyphene—CYP3A7—Vincristine—colon cancer	0.12	0.139	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.12	0.139	CbGbCtD
Dextropropoxyphene—CYP2C9—Capecitabine—colon cancer	0.111	0.13	CbGbCtD
Dextropropoxyphene—CYP2C8—Fluorouracil—colon cancer	0.0947	0.11	CbGbCtD
Dextropropoxyphene—CYP2C9—Fluorouracil—colon cancer	0.0661	0.0768	CbGbCtD
Dextropropoxyphene—CYP3A4—Irinotecan—colon cancer	0.04	0.0465	CbGbCtD
Dextropropoxyphene—CYP3A4—Vincristine—colon cancer	0.035	0.0407	CbGbCtD
Dextropropoxyphene—Hepatic steatosis—Capecitabine—colon cancer	0.00508	0.0373	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Irinotecan—colon cancer	0.00324	0.0238	CcSEcCtD
Dextropropoxyphene—Drug interaction—Vincristine—colon cancer	0.00254	0.0186	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Capecitabine—colon cancer	0.00217	0.0159	CcSEcCtD
Dextropropoxyphene—Coma—Vincristine—colon cancer	0.00215	0.0158	CcSEcCtD
Dextropropoxyphene—Coma—Fluorouracil—colon cancer	0.00201	0.0147	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Fluorouracil—colon cancer	0.00189	0.0138	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Irinotecan—colon cancer	0.00176	0.0129	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Irinotecan—colon cancer	0.00166	0.0122	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Vincristine—colon cancer	0.00163	0.0119	CcSEcCtD
Dextropropoxyphene—Ataxia—Vincristine—colon cancer	0.00161	0.0118	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Fluorouracil—colon cancer	0.00159	0.0117	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Irinotecan—colon cancer	0.00158	0.0116	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Fluorouracil—colon cancer	0.00152	0.0111	CcSEcCtD
Dextropropoxyphene—Ataxia—Fluorouracil—colon cancer	0.0015	0.011	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Vincristine—colon cancer	0.0013	0.00952	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Vincristine—colon cancer	0.00129	0.00947	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Capecitabine—colon cancer	0.00128	0.00935	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Irinotecan—colon cancer	0.00126	0.00927	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Irinotecan—colon cancer	0.00126	0.00922	CcSEcCtD
Dextropropoxyphene—Jaundice—Irinotecan—colon cancer	0.00125	0.00917	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Fluorouracil—colon cancer	0.00121	0.00888	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Fluorouracil—colon cancer	0.0012	0.00883	CcSEcCtD
Dextropropoxyphene—Hallucination—Vincristine—colon cancer	0.00118	0.00862	CcSEcCtD
Dextropropoxyphene—Bradycardia—Irinotecan—colon cancer	0.00117	0.00859	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Capecitabine—colon cancer	0.00111	0.00817	CcSEcCtD
Dextropropoxyphene—Visual impairment—Irinotecan—colon cancer	0.00111	0.00814	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Vincristine—colon cancer	0.0011	0.00804	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Irinotecan—colon cancer	0.00107	0.00783	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Vincristine—colon cancer	0.00107	0.00781	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Capecitabine—colon cancer	0.00106	0.00777	CcSEcCtD
Dextropropoxyphene—Ataxia—Capecitabine—colon cancer	0.00105	0.00768	CcSEcCtD
Dextropropoxyphene—Coma—Methotrexate—colon cancer	0.00104	0.00765	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Irinotecan—colon cancer	0.00104	0.00763	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Irinotecan—colon cancer	0.00104	0.00761	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Irinotecan—colon cancer	0.00103	0.00754	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Capecitabine—colon cancer	0.00103	0.00754	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Fluorouracil—colon cancer	0.000986	0.00722	CcSEcCtD
Dextropropoxyphene—Agitation—Vincristine—colon cancer	0.000946	0.00693	CcSEcCtD
Dextropropoxyphene—Vision blurred—Fluorouracil—colon cancer	0.000905	0.00663	CcSEcCtD
Dextropropoxyphene—Syncope—Irinotecan—colon cancer	0.000899	0.00659	CcSEcCtD
Dextropropoxyphene—Convulsion—Vincristine—colon cancer	0.000892	0.00654	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Irinotecan—colon cancer	0.000881	0.00646	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Methotrexate—colon cancer	0.000875	0.00642	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Capecitabine—colon cancer	0.000847	0.0062	CcSEcCtD
Dextropropoxyphene—Discomfort—Irinotecan—colon cancer	0.000843	0.00618	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Capecitabine—colon cancer	0.000842	0.00617	CcSEcCtD
Dextropropoxyphene—Jaundice—Capecitabine—colon cancer	0.000837	0.00613	CcSEcCtD
Dextropropoxyphene—Convulsion—Fluorouracil—colon cancer	0.000832	0.0061	CcSEcCtD
Dextropropoxyphene—Confusional state—Irinotecan—colon cancer	0.000825	0.00605	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Vincristine—colon cancer	0.000824	0.00604	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Capecitabine—colon cancer	0.000812	0.00595	CcSEcCtD
Dextropropoxyphene—Discomfort—Fluorouracil—colon cancer	0.000808	0.00592	CcSEcCtD
Dextropropoxyphene—Shock—Irinotecan—colon cancer	0.000805	0.0059	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Irinotecan—colon cancer	0.000803	0.00588	CcSEcCtD
Dextropropoxyphene—Confusional state—Fluorouracil—colon cancer	0.00079	0.00579	CcSEcCtD
Dextropropoxyphene—Hypotension—Vincristine—colon cancer	0.000785	0.00575	CcSEcCtD
Dextropropoxyphene—Bradycardia—Capecitabine—colon cancer	0.000785	0.00575	CcSEcCtD
Dextropropoxyphene—Ataxia—Methotrexate—colon cancer	0.00078	0.00572	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Fluorouracil—colon cancer	0.000769	0.00563	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Methotrexate—colon cancer	0.000766	0.00561	CcSEcCtD
Dextropropoxyphene—Tachycardia—Fluorouracil—colon cancer	0.000765	0.00561	CcSEcCtD
Dextropropoxyphene—Hypotension—Irinotecan—colon cancer	0.000765	0.0056	CcSEcCtD
Dextropropoxyphene—Insomnia—Vincristine—colon cancer	0.00076	0.00557	CcSEcCtD
Dextropropoxyphene—Visual impairment—Capecitabine—colon cancer	0.000743	0.00544	CcSEcCtD
Dextropropoxyphene—Insomnia—Irinotecan—colon cancer	0.00074	0.00542	CcSEcCtD
Dextropropoxyphene—Hypotension—Fluorouracil—colon cancer	0.000732	0.00537	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Irinotecan—colon cancer	0.00073	0.00535	CcSEcCtD
Dextropropoxyphene—Somnolence—Irinotecan—colon cancer	0.000727	0.00533	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Vincristine—colon cancer	0.000725	0.00532	CcSEcCtD
Dextropropoxyphene—Eye disorder—Capecitabine—colon cancer	0.00072	0.00528	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Irinotecan—colon cancer	0.00072	0.00528	CcSEcCtD
Dextropropoxyphene—Constipation—Vincristine—colon cancer	0.000719	0.00527	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Capecitabine—colon cancer	0.000715	0.00524	CcSEcCtD
Dextropropoxyphene—Insomnia—Fluorouracil—colon cancer	0.000709	0.0052	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Irinotecan—colon cancer	0.000706	0.00518	CcSEcCtD
Dextropropoxyphene—Constipation—Irinotecan—colon cancer	0.0007	0.00513	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Fluorouracil—colon cancer	0.000699	0.00512	CcSEcCtD
Dextropropoxyphene—Somnolence—Fluorouracil—colon cancer	0.000697	0.00511	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Capecitabine—colon cancer	0.000696	0.0051	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Capecitabine—colon cancer	0.000695	0.00509	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Fluorouracil—colon cancer	0.00069	0.00506	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Capecitabine—colon cancer	0.000689	0.00505	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Vincristine—colon cancer	0.000687	0.00504	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000677	0.00496	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Irinotecan—colon cancer	0.000674	0.00494	CcSEcCtD
Dextropropoxyphene—Malnutrition—Capecitabine—colon cancer	0.000671	0.00492	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Irinotecan—colon cancer	0.000669	0.0049	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Vincristine—colon cancer	0.000664	0.00487	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Irinotecan—colon cancer	0.000647	0.00474	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Fluorouracil—colon cancer	0.000646	0.00473	CcSEcCtD
Dextropropoxyphene—Toremifene—ABCB1—colon cancer	0.00064	0.18	CrCbGaD
Dextropropoxyphene—Drowsiness—Methotrexate—colon cancer	0.000639	0.00469	CcSEcCtD
Dextropropoxyphene—Vision blurred—Capecitabine—colon cancer	0.000632	0.00464	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Vincristine—colon cancer	0.000619	0.00454	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Methotrexate—colon cancer	0.000605	0.00443	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Irinotecan—colon cancer	0.000603	0.00442	CcSEcCtD
Dextropropoxyphene—Asthenia—Vincristine—colon cancer	0.000603	0.00442	CcSEcCtD
Dextropropoxyphene—Syncope—Capecitabine—colon cancer	0.000602	0.00441	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Capecitabine—colon cancer	0.00059	0.00432	CcSEcCtD
Dextropropoxyphene—Asthenia—Irinotecan—colon cancer	0.000587	0.0043	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Fluorouracil—colon cancer	0.000577	0.00423	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Vincristine—colon cancer	0.000575	0.00421	CcSEcCtD
Dextropropoxyphene—Phenylbutazone—PTGS2—colon cancer	0.000567	0.159	CrCbGaD
Dextropropoxyphene—Discomfort—Capecitabine—colon cancer	0.000564	0.00414	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Irinotecan—colon cancer	0.00056	0.0041	CcSEcCtD
Dextropropoxyphene—Dizziness—Vincristine—colon cancer	0.000556	0.00407	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methotrexate—colon cancer	0.000553	0.00405	CcSEcCtD
Dextropropoxyphene—Confusional state—Capecitabine—colon cancer	0.000552	0.00405	CcSEcCtD
Dextropropoxyphene—Dizziness—Irinotecan—colon cancer	0.000541	0.00397	CcSEcCtD
Dextropropoxyphene—Shock—Capecitabine—colon cancer	0.000539	0.00395	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Capecitabine—colon cancer	0.000537	0.00394	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methotrexate—colon cancer	0.000536	0.00393	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Fluorouracil—colon cancer	0.000536	0.00393	CcSEcCtD
Dextropropoxyphene—Tachycardia—Capecitabine—colon cancer	0.000535	0.00392	CcSEcCtD
Dextropropoxyphene—Vomiting—Vincristine—colon cancer	0.000534	0.00392	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methotrexate—colon cancer	0.000533	0.0039	CcSEcCtD
Dextropropoxyphene—Rash—Vincristine—colon cancer	0.00053	0.00388	CcSEcCtD
Dextropropoxyphene—Dermatitis—Vincristine—colon cancer	0.000529	0.00388	CcSEcCtD
Dextropropoxyphene—Headache—Vincristine—colon cancer	0.000526	0.00386	CcSEcCtD
Dextropropoxyphene—Vomiting—Irinotecan—colon cancer	0.00052	0.00381	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methotrexate—colon cancer	0.000518	0.0038	CcSEcCtD
Dextropropoxyphene—Dizziness—Fluorouracil—colon cancer	0.000518	0.0038	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methotrexate—colon cancer	0.000517	0.00379	CcSEcCtD
Dextropropoxyphene—Rash—Irinotecan—colon cancer	0.000516	0.00378	CcSEcCtD
Dextropropoxyphene—Dermatitis—Irinotecan—colon cancer	0.000515	0.00378	CcSEcCtD
Dextropropoxyphene—Headache—Irinotecan—colon cancer	0.000513	0.00376	CcSEcCtD
Dextropropoxyphene—Hypotension—Capecitabine—colon cancer	0.000512	0.00375	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methotrexate—colon cancer	0.0005	0.00366	CcSEcCtD
Dextropropoxyphene—Nausea—Vincristine—colon cancer	0.000499	0.00366	CcSEcCtD
Dextropropoxyphene—Vomiting—Fluorouracil—colon cancer	0.000498	0.00365	CcSEcCtD
Dextropropoxyphene—Insomnia—Capecitabine—colon cancer	0.000495	0.00363	CcSEcCtD
Dextropropoxyphene—Rash—Fluorouracil—colon cancer	0.000494	0.00362	CcSEcCtD
Dextropropoxyphene—Dermatitis—Fluorouracil—colon cancer	0.000494	0.00362	CcSEcCtD
Dextropropoxyphene—Headache—Fluorouracil—colon cancer	0.000491	0.0036	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Capecitabine—colon cancer	0.000488	0.00358	CcSEcCtD
Dextropropoxyphene—Nausea—Irinotecan—colon cancer	0.000486	0.00356	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Capecitabine—colon cancer	0.000482	0.00353	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Capecitabine—colon cancer	0.000473	0.00347	CcSEcCtD
Dextropropoxyphene—Vision blurred—Methotrexate—colon cancer	0.000471	0.00345	CcSEcCtD
Dextropropoxyphene—Constipation—Capecitabine—colon cancer	0.000468	0.00343	CcSEcCtD
Dextropropoxyphene—Nausea—Fluorouracil—colon cancer	0.000466	0.00341	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Capecitabine—colon cancer	0.000451	0.00331	CcSEcCtD
Dextropropoxyphene—Propafenone—ABCB1—colon cancer	0.000451	0.127	CrCbGaD
Dextropropoxyphene—Gastrointestinal pain—Capecitabine—colon cancer	0.000448	0.00328	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Capecitabine—colon cancer	0.000433	0.00317	CcSEcCtD
Dextropropoxyphene—Convulsion—Methotrexate—colon cancer	0.000433	0.00317	CcSEcCtD
Dextropropoxyphene—Discomfort—Methotrexate—colon cancer	0.00042	0.00308	CcSEcCtD
Dextropropoxyphene—Confusional state—Methotrexate—colon cancer	0.000411	0.00301	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Capecitabine—colon cancer	0.000404	0.00296	CcSEcCtD
Dextropropoxyphene—Bepridil—ABCB1—colon cancer	0.000402	0.113	CrCbGaD
Dextropropoxyphene—Nervous system disorder—Methotrexate—colon cancer	0.0004	0.00293	CcSEcCtD
Dextropropoxyphene—Asthenia—Capecitabine—colon cancer	0.000393	0.00288	CcSEcCtD
Dextropropoxyphene—Hypotension—Methotrexate—colon cancer	0.000381	0.00279	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Capecitabine—colon cancer	0.000375	0.00275	CcSEcCtD
Dextropropoxyphene—Fentanyl—ABCB1—colon cancer	0.000369	0.104	CrCbGaD
Dextropropoxyphene—Insomnia—Methotrexate—colon cancer	0.000369	0.0027	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Methotrexate—colon cancer	0.000363	0.00266	CcSEcCtD
Dextropropoxyphene—Somnolence—Methotrexate—colon cancer	0.000362	0.00266	CcSEcCtD
Dextropropoxyphene—Dizziness—Capecitabine—colon cancer	0.000362	0.00265	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methotrexate—colon cancer	0.000359	0.00263	CcSEcCtD
Dextropropoxyphene—Loperamide—ABCB1—colon cancer	0.000356	0.0999	CrCbGaD
Dextropropoxyphene—Gastrointestinal disorder—Methotrexate—colon cancer	0.000352	0.00258	CcSEcCtD
Dextropropoxyphene—Vomiting—Capecitabine—colon cancer	0.000348	0.00255	CcSEcCtD
Dextropropoxyphene—Rash—Capecitabine—colon cancer	0.000345	0.00253	CcSEcCtD
Dextropropoxyphene—Dermatitis—Capecitabine—colon cancer	0.000345	0.00253	CcSEcCtD
Dextropropoxyphene—Headache—Capecitabine—colon cancer	0.000343	0.00251	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methotrexate—colon cancer	0.000336	0.00246	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methotrexate—colon cancer	0.000333	0.00244	CcSEcCtD
Dextropropoxyphene—Nausea—Capecitabine—colon cancer	0.000325	0.00238	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methotrexate—colon cancer	0.000322	0.00236	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methotrexate—colon cancer	0.0003	0.0022	CcSEcCtD
Dextropropoxyphene—Asthenia—Methotrexate—colon cancer	0.000293	0.00214	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methotrexate—colon cancer	0.000279	0.00204	CcSEcCtD
Dextropropoxyphene—Dizziness—Methotrexate—colon cancer	0.00027	0.00198	CcSEcCtD
Dextropropoxyphene—Trimipramine—ABCB1—colon cancer	0.000267	0.0751	CrCbGaD
Dextropropoxyphene—Vomiting—Methotrexate—colon cancer	0.000259	0.0019	CcSEcCtD
Dextropropoxyphene—Rash—Methotrexate—colon cancer	0.000257	0.00188	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methotrexate—colon cancer	0.000257	0.00188	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ABCB1—colon cancer	0.000256	0.0718	CrCbGaD
Dextropropoxyphene—Headache—Methotrexate—colon cancer	0.000255	0.00187	CcSEcCtD
Dextropropoxyphene—Methadone—ABCB1—colon cancer	0.000253	0.0712	CrCbGaD
Dextropropoxyphene—Nausea—Methotrexate—colon cancer	0.000242	0.00177	CcSEcCtD
